Ficha del valor · trimestre archivado
AVXL
Anavex Life Sciences Corp. · Healthcare · Biotechnology
14Tenedores rastreados
0Δ titulares
20.35MAcciones mantenidas
$181.11MValor declarado
+0Nuevas posiciones
−0Cierres
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones +2.9% · nuevas posiciones netas 0.0% — fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
Participación a lo largo del tiempo
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 80 | -1 | 31.52M | $81.72M | +7 | −8 |
| Q1 2026 | 83 | +4 | 34.46M | $105.82M | +13 | −9 |
| Q4 2025 | 79 | +2 | 31.53M | $112.26M | +2 | — |
| Q3 2025 | 14 | 0 | 20.35M | $181.11M | — | — |
| Q2 2025 | 11 | -2 | 18.83M | $173.63M | — | −2 |
| Q1 2025 | 10 | -1 | 6.83M | $58.56M | — | −1 |
| Q4 2024 | 11 | +3 | 6.21M | $66.68M | +3 | — |
| Q3 2024 | 7 | -2 | 3.52M | $20.02M | — | −2 |
| Q2 2024 | 9 | — | 3.99M | $16.85M | — | — |
Quién lo tiene en cartera · Q3 2025
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasivo) | 7.19M | +2.7% | $63.98M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | BlackRock ✦ (pasivo) | 7.19M | +2.7% | $63.98M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | BlackRock ✦ (pasivo) | 7.19M | +2.7% | $63.98M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | BlackRock ✦ (pasivo) | 7.19M | +2.7% | $63.98M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | BlackRock ✦ (pasivo) | 7.19M | +2.7% | $63.98M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (pasivo) | 7.19M | +2.7% | $63.98M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (pasivo) | 7.19M | +2.7% | $63.98M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (pasivo) | 7.19M | +2.7% | $63.98M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | BlackRock ✦ (pasivo) | 7.19M | +2.7% | $63.98M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | BlackRock ✦ (pasivo) | 7.19M | +2.7% | $63.98M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | BlackRock ✦ (pasivo) | 7.19M | +2.7% | $63.98M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | The Vanguard Group ✦ (pasivo) | 5.10M | -0.1% | $45.43M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | The Vanguard Group ✦ (pasivo) | 5.10M | -0.1% | $45.43M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | The Vanguard Group ✦ (pasivo) | 5.10M | -0.1% | $45.43M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | The Vanguard Group ✦ (pasivo) | 5.10M | -0.1% | $45.43M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | The Vanguard Group ✦ (pasivo) | 5.10M | -0.1% | $45.43M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | State Street Global Advisors ✦ (pasivo) | 3.29M | +11.5% | $29.26M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 18 | Geode Capital Management ✦ (pasivo) | 2.03M | +0.4% | $18.05M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 19 | Geode Capital Management ✦ (pasivo) | 2.03M | +0.4% | $18.05M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 20 | Two Sigma Investments ✦ | 1.04M | +6.5% | $9.23M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 21 | Morgan Stanley ✦ | 560.15K | — | $4.99M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Morgan Stanley ✦ | 560.15K | — | $4.99M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Morgan Stanley ✦ | 560.15K | — | $4.99M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Morgan Stanley ✦ | 560.15K | — | $4.99M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Morgan Stanley ✦ | 560.15K | — | $4.99M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Goldman Sachs Group ✦ | 303.39K | — | $2.70M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Goldman Sachs Group ✦ | 303.39K | — | $2.70M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Wellington Management ✦ | 288.81K | +48.2% | $2.57M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 29 | Wellington Management ✦ | 288.81K | +48.2% | $2.57M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 30 | Wellington Management ✦ | 288.81K | +48.2% | $2.57M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 31 | Citadel Advisors ✦ | 195.72K | -39.2% | $1.74M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 32 | Citadel Advisors ✦ | 195.72K | -39.2% | $1.74M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 33 | Marshall Wace ✦ | 182.19K | 0.0% | $1.62M | 0.0% | Held | 4 | SEC ↗ |
| 34 | Marshall Wace ✦ | 182.19K | 0.0% | $1.62M | 0.0% | Held | 4 | SEC ↗ |
| 35 | JPMorgan Chase ✦ | 90.13K | — | $802,158 | 0.0% | n/c | 1 | SEC ↗ |
| 36 | JPMorgan Chase ✦ | 90.13K | — | $802,158 | 0.0% | n/c | 1 | SEC ↗ |
| 37 | JPMorgan Chase ✦ | 90.13K | — | $802,158 | 0.0% | n/c | 1 | SEC ↗ |
| 38 | JPMorgan Chase ✦ | 90.13K | — | $802,158 | 0.0% | n/c | 1 | SEC ↗ |
| 39 | JPMorgan Chase ✦ | 90.13K | — | $802,158 | 0.0% | n/c | 1 | SEC ↗ |
| 40 | JPMorgan Chase ✦ | 90.13K | — | $802,158 | 0.0% | n/c | 1 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 90.13K | — | $802,158 | 0.0% | n/c | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 90.13K | — | $802,158 | 0.0% | n/c | 1 | SEC ↗ |
| 43 | T. Rowe Price ✦ | 45.61K | +9.2% | $406,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 44 | AQR Capital Management ✦ | 28.04K | -3.5% | $249,517 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 45 | AQR Capital Management ✦ | 28.04K | -3.5% | $249,517 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 46 | AQR Capital Management ✦ | 28.04K | -3.5% | $249,517 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 47 | AQR Capital Management ✦ | 28.04K | -3.5% | $249,517 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 48 | Fidelity (FMR) ✦ | 10.61K | +1.9% | $94,380 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 49 | Fidelity (FMR) ✦ | 10.61K | +1.9% | $94,380 | 0.0% | ▲ Add | 2 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1 tenedores, 39.00K acciones, $119 declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Frecuentemente cotituladas
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Procedencia: Participación a partir de posiciones en acciones ordinarias de 13F procesadas (universo rastreado, conjuntos comparables para cambios); filas de iniciados de los Formularios 3/4/5; participaciones de los Schedules 13D/13G; cada filing enlaza con su original en SEC EDGAR.
Período de reporte: Q3 2025 ·
Metodología ·
Obtener esto a través de la API